Akebia Therapeutics
(AKBA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,780 | 21,215 | 1,641 | N/A | N/A |
| Marketable Securities | 76,138 | 11,341 | N/A | N/A | N/A |
| Receivables | N/A | 135 | 86 | N/A | N/A |
| TOTAL | $110,480 | $33,431 | $2,244 | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 210 | 30 | N/A | N/A | N/A |
| Other Non-Current Assets | 305 | 1,204 | 0 | 0 | 0 |
| TOTAL | $515 | $1,234 | $N/A | $N/A | $N/A |
| Total Assets | $110,995 | $34,665 | $2,244 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,021 | 714 | 418 | 0 | 0 |
| Accrued Expenses | 4,864 | 3,188 | 351 | N/A | N/A |
| Other current liabilities | N/A | N/A | 4,154 | N/A | N/A |
| TOTAL | $6,885 | $3,902 | $4,923 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32 | 8 | 0 | 0 | 0 |
| TOTAL | $32 | $8 | $N/A | $N/A | $N/A |
| Total Liabilities | $6,917 | $3,910 | $4,923 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,371 | N/A | N/A | N/A | N/A |
| Retained earnings | -100,673 | -127,072 | -59,588 | N/A | N/A |
| Other shareholders' equity | -218 | 157,827 | 56,909 | 0 | 0 |
| TOTAL | $104,078 | $30,755 | $-2,680 | $N/A | $N/A |
| Total Liabilities And Equity | $110,995 | $34,665 | $2,244 | $0 | $0 |